Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarker

Abstract

Our findings show that ASF1B may serve as a prognostic marker and potential immunotherapeutic target for several malignancies due to its role in tumorigenesis and immune infiltration.